Cannabis in Saskatchewan

Aurora Cannabis to Participate in Three Upcoming Virtual Investor Conferences

Retrieved on: 
Friday, May 28, 2021
Cannabis, Cannabis in Alberta, Psychoactive drugs, Aurora Cannabis, Chicago metropolitan area, Cannabis in Saskatchewan, Aurora Publishing, Aurora, Illinois, Legality of cannabis, CanniMed

EDMONTON, AB, May 28, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that management will participate in three upcoming investor conferences.

Key Points: 
  • EDMONTON, AB, May 28, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced that management will participate in three upcoming investor conferences.
  • From June 1 -2, 2021, Miguel Martin, CEO and Glen Ibbott, CFO will participate in the Jefferies Virtual Healthcare Conference.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD.

American Cannabis Company, Inc. Announces Formation of Advisory Board

Retrieved on: 
Thursday, March 18, 2021
Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Drugs, Cannabis law, Drug control law, Legality of cannabis, Medical cannabis, Cannabis in Saskatchewan, Medical cannabis in the United States

These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Key Points: 
  • These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations.
  • Although legalized in some states, cannabis is a Schedule 1 drug under the Controlled Substances Act (21 U.S.C.
  • This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses.

American Cannabis Company, Inc. Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado

Retrieved on: 
Tuesday, March 16, 2021
Herbalism, Medicinal plants, Cannabis, Drugs in the United States, Drugs, Cannabis law, Drug control law, Legality of cannabis, Medical cannabis, Cannabis in Saskatchewan, Medical cannabis in the United States

These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.

Key Points: 
  • These or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Territories currently have laws broadly legalizing cannabis in some form for either medicinal and/or recreational use governed by state specific laws and regulations.
  • Although legalized in some states, cannabis is a Schedule 1 drug under the Controlled Substances Act (21 U.S.C.
  • This law allows publicly traded corporations to apply for and qualify for the ownership of Colorado cannabis licenses.

Aurora Cannabis to Host Second Quarter Fiscal Year 2021 Investor Conference Call

Retrieved on: 
Thursday, January 28, 2021
Cannabis, Health sciences, Cannabis in Saskatchewan, CanniMed, Aurora, Illinois, Medical cannabis, Medicine, Aurora Cannabis

Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.

Key Points: 
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD.
  • Providing customers with innovative, high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.
  • This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

Health Canada releases new data on cannabis use in Canada

Retrieved on: 
Monday, December 21, 2020
Herbalism, Medicinal plants, Cannabis, Health sciences, Drugs, Cannabis smoking, Entheogens, Medical cannabis, Cannabis in Saskatchewan, Cannabis in Prince Edward Island

On October 17, 2018, the Cannabis Act came into force, providing a strict national framework for controlling the production, distribution, sale and possession of cannabis in Canada.

Key Points: 
  • On October 17, 2018, the Cannabis Act came into force, providing a strict national framework for controlling the production, distribution, sale and possession of cannabis in Canada.
  • Today, Health Canada published the results of its 2020 Canadian Cannabis Survey.
  • Driving after cannabis use has decreased among those who reported past 12-month cannabis use, as compared to 2019 results.
  • Health Canada commissioned the inaugural Canadian Cannabis Survey in 2017.

Solar Therapeutics Reopens Adult-Use Cannabis Dispensary With Curbside Pickup Beginning Monday, May 25, 2020

Retrieved on: 
Friday, May 22, 2020
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Legality of cannabis, Cannabis in Saskatchewan

SOMERSET, Mass., May 22, 2020 /PRNewswire/ -- Solar Therapeutics (Solar) - America's only energy-independent cannabis company - today announced that it will reopen its doors to the public for adult use cannabis sales beginning Monday, May 25, 2020.

Key Points: 
  • SOMERSET, Mass., May 22, 2020 /PRNewswire/ -- Solar Therapeutics (Solar) - America's only energy-independent cannabis company - today announced that it will reopen its doors to the public for adult use cannabis sales beginning Monday, May 25, 2020.
  • Since closing its dispensary doors after Governor Baker's "non-essential" designation to adult-use cannabis, Solar will officially resume recreational sales at its Somerset, Mass.
  • There's no way around it," said Edward Dow, Solar Therapeutics CEO.
  • Solar is a 70,000 square foot marijuana cultivation facility coupled with on-site and off-site dispensary storefronts that supply both medical and recreational cannabis products.

Aurora Cannabis to Host Third Quarter 2020 Investor Conference Call

Retrieved on: 
Friday, May 1, 2020
Companies, Consumer electronics, Cannabis in Saskatchewan, CanniMed, Pioneer Corporation, Caterpillar Inc., Cannabis, Aurora Cannabis

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.

Key Points: 
  • Aurora is a global leader in the cannabis industry serving both the medical and consumer markets.
  • Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives.
  • The Company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and ROAR Sports.
  • This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements").

ZYUS and University of Saskatchewan Partner to Conduct Cannabinoid-Based Research on Possible Treatment of Brain Disorders

Retrieved on: 
Tuesday, January 7, 2020
Biotechnology, Pharmaceutical, Alternative medicine, Health, Other Education, Education, Clinical trials, Other Health, Cannabinoid Research Initiative of Saskatchewan, Cannabis in Saskatchewan, University of Saskatchewan, Cris, Cannabinoid

Dr. Zhang is a member of the University of Saskatchewan--led Cannabinoid Research Initiative of Saskatchewan (CRIS), an interdisciplinary network of leading scientists active in the field of cannabinoids.

Key Points: 
  • Dr. Zhang is a member of the University of Saskatchewan--led Cannabinoid Research Initiative of Saskatchewan (CRIS), an interdisciplinary network of leading scientists active in the field of cannabinoids.
  • We are excited to partner with Dr. Zhangs team at the University of Saskatchewans College of Medicine on this advanced, patient-focused, cannabinoid-based formulation project, said Brent Zettl, President and CEO of ZYUS.
  • The aim of the pre-clinical study is to help advance understanding of how cannabinoids can effectively treat mental health conditions.
  • Visit www.zyus.com
    One of Canadas top research universities, the University of Saskatchewan (USask) is home to world-leading research in areas of global importance, such as water and food security.

INVICTUS ANNOUNCES TERMINATION OF THE PREVIOUSLY ANNOUNCED BINDING LETTER OF INTENT WITH UNIFIED CANNABIS CORP.

Retrieved on: 
Friday, January 3, 2020
Drug control law, Health, Access to Cannabis for Medical Purposes Regulations, Pharmaceuticals policy, Cannabis, Medicine, Legality of cannabis, Cannabis in Saskatchewan, Cannabis in Nova Scotia

To meet growing demand, Invictus is expanding its cultivation footprint with two cannabis production facilities licensed under the Cannabis Act, which replaced the Access to Cannabis for Medical Purposes Regulations in Canada.

Key Points: 
  • To meet growing demand, Invictus is expanding its cultivation footprint with two cannabis production facilities licensed under the Cannabis Act, which replaced the Access to Cannabis for Medical Purposes Regulations in Canada.
  • Another of Invictus wholly owned subsidiaries, 2015059 Alberta Ltd. (dba Leaf Wise), continues to connect medical clients to physicians for medical cannabis and to Invictus fully licensed cannabis producers under the Cannabis Act.
  • Invictus is targeting up to 50 percent of production to medical cannabis.
  • Invictus drives sustainable long-term shareholder value by continuing to develop Invictus Canadian production of medical and recreational cannabis products.

M&A News: Cannabis One and ONE Cannabis Unite, Primed to Transform the Future of Cannabis

Retrieved on: 
Wednesday, December 11, 2019
Retail, Consumer, Other Retail, Women, Tobacco, Specialty, MEN, Cannabis, Cannabis smoking, Entheogens, Euphoriants, Drugs, Medicine, Cannabis in Canada, Cannabis in Saskatchewan, Cannabis One, ONE Cannabis Group

Both are cannabis leaders in their own right, their combined prowess creates a strong, national force among cannabis retail and product brands alike.

Key Points: 
  • Both are cannabis leaders in their own right, their combined prowess creates a strong, national force among cannabis retail and product brands alike.
  • Meanwhile, ONE Cannabis has paved the way for franchising cannabis dispensaries in the United States with more than a dozen deals signed in new and emerging markets nationwide.
  • Together, Cannabis One and ONE Cannabis will lead the industry into a truly successful Cannabis 2.0 with our winning combination.
  • Its award-winning Green Man Cannabis is well-known for its connoisseur-grade craft cannabis and numerous Cannabis Cup wins.